West Pharmaceutical Services, Inc. (WST) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for West Pharmaceutical Services, Inc. (WST:NYSE), powered by AI.

Current Price
$329.58
P/E Ratio
48.3
Market Cap
23.8B
Sector
Healthcare
What is the West Pharmaceutical Services, Inc. stock price forecast?

West Pharmaceutical Services, Inc. is currently trading at $329.58. View real-time AI analysis on Alpha Lenz.

What is West Pharmaceutical Services, Inc. insider trading activity?

View the latest insider trading data for West Pharmaceutical Services, Inc. on Alpha Lenz.

What is West Pharmaceutical Services, Inc.'s P/E ratio?

West Pharmaceutical Services, Inc.'s P/E ratio is 48.3.

West Pharmaceutical Services, Inc.

NYSE · WST
$329.58-1.85(-0.56%)Pre-marketNYSE regular session 09:30–16:00 ET
Ask about West Pharmaceutical Services, Inc.'s future dividend policy...
Alpha Chat Insight

West Pharmaceutical Services, Inc. trades at a P/E of 48.3 (premium valuation) with strong ROE of 16.9%. Operating margin of 20.7% indicates strong profitability.

Ask for details

Company Overview

West Pharmaceutical Services, Inc. is a leading provider of innovative solutions for injectable drug administration, operating in the life sciences tools and services industry. Established in 1923, the company specializes in the design and manufacture of containment and delivery systems for injectable pharmaceuticals and healthcare products. Its product portfolio primarily includes components and systems such as stoppers, seals, vials, and syringes, serving pharmaceutical, biotechnology, and medical device companies globally. These products are critical to ensuring the safety, efficacy, and integrity of medicines, particularly in sterile environments. West Pharmaceutical Services plays a vital role in supporting the pharmaceutical supply chain, addressing the stringent regulatory demands of the healthcare sector. The company is recognized for driving innovation in parenteral drug packaging and delivery, contributing to advances in both drug safety and patient outcomes. With a significant presence across international markets, West Pharmaceutical Services is regarded as a key partner for industry leaders engaged in the development and distribution of injectable therapies.

CEOMr. Eric M. Green
SectorHealthcare
IndustryMedical Instruments & Supplies
Employees10,600

Company Statistics

FY 2025

Profile

$23.83BMarket Cap
$3.07BRevenue
0.00Shares Out
10,600Employees

Margins

35.91%Gross
26.76%EBITDA
20.69%Operating
19.55%Pre-Tax
16.06%Net

Valuation

48.27P/E
7.50P/B
7.75EV/Sales
28.39EV/EBITDA
50.82P/FCF

Growth (CAGR)

2.12%Rev 3Yr
7.44%Rev 5Yr
-5.79%Op Inc 3Yr
8.71%Op Inc 5Yr
-5.55%Net Inc 3Yr
7.36%Net Inc 5Yr

Returns

12.48%ROA
16.85%ROE
16.08%ROIC

Financial Health

$791.30MCash & Cash Equivalents
$302.70MNet Debt
34.45%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

West Pharmaceutical Services, Inc. (ticker: WST) is a company listed on NYSE in the Healthcare sector (Medical Instruments & Supplies). It has approximately 10,600 employees. Market cap is $23.8B.

The current price is $329.58 with a P/E ratio of 48.27x and P/B of 7.5x.

ROE is 16.85% and operating margin is 20.69%. Annual revenue is $3.1B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
West Pharmaceutical Services, Inc. (WST) Stock Forecast 2026 $329.58 — Price, Financials & Analyst Targets | Alpha Lenz